NexGen
Device Knees
PDI 00889024563896
General payments
$2,146,832
Research payments
$50,764
Through program year 2025, $2,146,832 in general payments and $50,764 in research payments were reported against NexGen (Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $18,136 | 13 |
| 2024 | General | $6,004 | 16 |
| 2024 | Research | $8,547 | 3 |
| 2023 | General | $2,111,592 | 55 |
| 2023 | Research | $21,031 | 12 |
| 2022 | General | $11,101 | 14 |
| 2022 | Research | $21,186 | 6 |
Breakdown
The top 5 of 6 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
98 general · 21 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.